A study to test the effectiveness of varying doses of ropinirole PR while taking L-dopa in patients with late stage Parkinson's disease. A study to test the effectiveness of varying doses of ropinirole PR while taking L-dopa in patients ...
A fixed dose, dose-response study of ropinirole prolonged release (PR) as adjunctive treatment to L-dopa in patients with advanced Parkinson's disease. A fixed dose, dose-response study of ropinirole prolonged release (PR) as adjunctive treatment to L- ...
Advanced Parkinson's disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Parkinson's disease;System Organ Class: 10029205 - Nervous system disorders;Therapeutic area: Diseases [C] - Nervous System Diseases [C10] Advanced Parkinson's disease. MedDRA version: 14.1;Level: PT;Classification code 10061536;Term: Park ...
Trade Name: REQUIP-MODUTAB, 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Proposed INN: ROPINIROLE Trade Name: REQUIP-MODUTAB, 4mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Proposed INN: ROPINIROLE Trade Name: REQUIP-MODUTAB, 8mg Product Name: ropinirole PR Product Code: SK&F101468 INN or Proposed INN: ROPINIROLE Trade Name: REQUIP-MODUTAB, 2mg Product Name: ropinirole PR, 2mg Product Code: SK&F101468 INN or Propos ...
GlaxoSmithKline Research & Development Limited
NULL
Not Recruiting
Female: yes Male: yes
406
United States;Taiwan;Estonia;Slovakia;Argentina;Chile;Russian Federation;Korea, Republic of